A scheduled cell-assay week has a way of exposing weak paperwork. If the cells, media and plates are ready but the batch documentation is not, the run is exposed to avoidable ambiguity. For laboratory researchers and materials managers working with research-use-only materials, heavy-metal screening should be treated as a documentation check: a line of evidence tied to a specific batch, not a phrase on a product page. Research Sciences describes full-spectrum testing that includes purity, identity, heavy metals and endotoxin evaluation of submitted samples, with CoAs linked to supported products. That description is a prompt to open the batch document, not a substitute for it. None of these materials are for human or veterinary use.
What a Heavy-Metal Screen Actually Documents
Heavy-metal screening is often spoken about as though it were a single, self-proving label. In practice, it is a documentation trail. For a research-use-only peptide, the relevant question is not whether a site mentions heavy metals, but whether the CoA accompanying the specific batch records the analytical work in a way that a laboratory can file, review and trace. The shop’s About page describes an expanded testing framework with heavy metals and endotoxin screening alongside CoA documentation. The blog material discusses heavy-metal testing in the context of ICP-MS. Those are site-published educational points; they do not replace the actual batch CoA, and no pass/fail limit should be inferred from a general article.
Match the vial, the reference and the report
Vial labels use a reference format that combines SKU code and expiry date, for example BPC10-03/27, and that reference links to the corresponding CoA. A materials manager should check that the reference on the vial, the reference on the CoA and the catalogue item all agree before the assay week begins. Cap colour is not an indicator of identity, analytical quality or manufacturing origin. Nor is a shared Internal Test Reference (ITR) a guarantee that separate deliveries come from the same production lot or have had separate independent testing; the FAQs state that an ITR links to associated sample testing reports, nothing more.
A screen is not a slogan
A slogan says “screened”. A documentation check asks: which batch, which sample, which method, which report, which date, and does the record travel with the material into the laboratory? The homepage lists “CoAs Janoshik Analytical Reports” and “≥99% Verified Purity”, but these are published lines that should be reconfirmed on the live site and, above all, on the batch CoA. The FAQs say peptides are typically supplied at ≥99% purity by HPLC and that exact purity is stated on the CoA. Heavy-metal screening sits alongside purity and identity, and endotoxin where recorded, as part of contaminant evaluation. It is not a badge that can be copied from one product page to another. For cell-assay planning, that distinction matters: the documentation must be specific enough to file before the first plate is seeded.
Assembling a Pre-Assay Documentation File for the Bench
Before a scheduled cell-assay week, build a documentation file that is separate from the order confirmation. It should contain the batch CoA for each catalogue item, the vial reference, the ITR where supplied, storage and dispatch records, and a note of any in-vitro reconstitution calculation used to prepare working concentrations. Catalogue examples such as BPC-157 10mg, TB-500 5mg, GHK-Cu 50mg, Ipamorelin 5mg or CJC-1295 (No DAC) 5mg are separate items with separate documentation; one CoA should not be treated as covering another product or another delivery. The shop states that every product includes a CoA for purity and identity by HPLC, and that compounds are independently tested and subject to final verification and quality checks in the UK before release. Those statements should be checked against the actual documents in hand.
Storage records belong in the same file. Lyophilised peptides should be stored at –20°C or below, sealed with desiccant and protected from moisture, heat and light; repeated freeze–thaw cycles should be avoided. Reconstituted material is less stable and should be kept at 2–8°C for short-term laboratory use. The free reconstitution calculator is described for laboratory research use only, using mg, mcg, mL and U-100/U-50 syringe scales; it must not be used for human or veterinary dosing. None of the materials are medicines, medical devices, injectables, treatments or food supplements under UK law; they are not for human or veterinary use, consumption, administration or clinical application. The purchaser remains responsible for lawful use, safe handling, storage, disposal and COSHH compliance.
For UK laboratories comparing catalogue items, Uk peptides catalogue listings should be read alongside the batch CoA rather than instead of it. The homepage’s “24hr UK Delivery” line is a marketing statement; the FAQs describe next-working-day dispatch via Royal Mail Tracked 24, with delivery usually the following working day as a Royal Mail estimate, not a guarantee. Tracking numbers are provided after dispatch, and delivery times can vary in peak periods, so current wording should be reconfirmed at checkout. The documentation file should therefore record what was dispatched, when, and which batch reference arrived, so that any discrepancy is caught before assay week rather than during it.
When the Assay Week Is Already Scheduled: Scenarios and Checks
Scenario one: a restock arrives with the same ITR as earlier stock. This is not proof that the two deliveries share a production lot or that the later delivery has had separate independent testing. The ITR links to associated sample testing reports; it does not collapse separate deliveries into one batch. Check the vial reference, open the CoA and record the delivery date. If the documentation does not match, raise it before the assay week, quoting the label reference.
Scenario two: a shared freezer and a busy bench. Lyophilised vials should be allowed to reach room temperature before opening, opened in a clean environment, and only the amount required for the experiment removed. Storage at –20°C or below, with desiccant and protection from light, should be documented. Repeated freeze–thaw cycles should be avoided. For in-vitro work, reconstitution is a laboratory step: diluent volume and target concentration are recorded for the assay, not for administration. The shop’s calculator is for laboratory research use only and must not be used for human or veterinary dosing.
Scenario three: a request for a blended peptide. The FAQs state that the shop does not supply blended peptides, such as Ipamorelin plus CJC-1295, and recommends buying peptides individually and combining only within a controlled experimental design. That makes documentation even more important: each individual batch has its own CoA, its own reference and its own storage record. A blended request can obscure which batch was tested and which report applies.
Scenario four: cap colour changes. Packaging may vary, but cap colour is not an indicator of identity, analytical quality or manufacturing origin. The CoA and label reference are the documents to trust, not the cap. Scenario five: heavy-metal screening and endotoxin screening are treated as one line. They are separate contaminant evaluations; where a batch CoA records them, read each result separately and do not infer one from the other. A practical sign-off sheet can list the assay date, item, SKU-expiry reference, CoA on file, ITR, storage check, in-vitro reconstitution record and handler initials. That sheet turns heavy-metal screening from a slogan into a documentation check. All materials remain research-use-only and are not for human or veterinary use.
Busan robotics engineer roaming Casablanca’s medinas with a mirrorless camera. Mina explains swarm drones, North African street art, and K-beauty chemistry—all in crisp, bilingual prose. She bakes Moroccan-style hotteok to break language barriers.